CASI Pharmaceuticals Inc Logo Image

CASI Pharmaceuticals Inc

Most Recent Annual Report

2016 Annual Report and Form 10K

CASI Pharmaceuticals Inc

Archived Annual Reports

  • CASI Pharmaceuticals Inc
  • CASI Pharmaceuticals Inc
  • CASI Pharmaceuticals Inc

About CASI Pharmaceuticals Inc

Based in Rockville, Maryland

CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company’s lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myeloma, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer.

Ticker:
CASI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol